InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-15.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Bensen Daniel, Executive. Officer active across 1 company, notably Tyra Biosciences, Inc.. In total, 24 disclosures have been recorded. Split: 0 buy · 13 sells. Total volume traded: €1.8m. Activity tracked since 21 March 2023. The latest transaction was disclosed on 12 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations24 total
2,128 shares@ US$31.5018Common StockSEC:0001193125-26-051534:0
6,983 shares@ US$28.44231.4% of flowCommon StockSEC:0001193125-26-016651:0
1,017 shares@ US$29.08084.7% of flowCommon StockSEC:0001193125-26-016651:1
8,000 shares@ US$22.64498.8% of flowCommon StockSEC:0001193125-25-320941:0
75,633 shares@ US$16.072765.2% of flowCommon StockSEC:0001193125-25-288529:0
1,111 shares@ US$16.00362.7% of flowCommon StockSEC:0001193125-25-284935:0
200 shares@ US$20.000.7% of flowCommon StockSEC:0000950170-24-071500:0
200 shares@ US$20.000.7% of flowCommon StockSEC:0000950170-24-030932:0
1,733 shares@ US$20.0925.9% of flowCommon StockSEC:0000950170-24-028807:0
2,900 shares@ US$20.03869.9% of flowCommon StockSEC:0000950170-24-026365:0
745 shares@ US$20.002.5% of flowCommon StockSEC:0000950170-24-023406:0
1,501 shares@ US$20.005.1% of flowCommon StockSEC:0000950170-24-015559:0
9,587 shares@ US$18.093929.7% of flowCommon StockSEC:0000950170-24-013474:0
25,393 shares@ US$0.612.6% of flowCommon StockSEC:0000950170-24-011880:0
207 shares@ US$0.610.0% of flowCommon StockSEC:0001209191-23-043165:0
500 shares@ US$0.610.0% of flowCommon StockSEC:0001209191-23-042495:0
1,202 shares@ US$0.610.1% of flowCommon StockSEC:0001209191-23-042114:0
17,281 shares@ US$0.611.8% of flowCommon StockSEC:0001209191-23-040654:0
17,232 shares@ US$0.611.8% of flowCommon StockSEC:0001209191-23-040105:0
5,628 shares@ US$0.610.6% of flowCommon StockSEC:0001209191-23-037611:0
2,000 shares@ US$0.610.2% of flowCommon StockSEC:0001209191-23-022432:0
8,048 shares@ US$0.610.8% of flowCommon StockSEC:0001209191-23-021564:0
14,100 shares@ US$0.611.5% of flowCommon StockSEC:0001209191-23-020846:0
8,501 sharesCommon StockSEC:0000899243-21-036432:0
24 of 24 declarations
About Bensen Daniel
Daniel Bensen is the Chief Operating Officer at Tyra Biosciences, Inc. In this role, he oversees the company's operations, ensuring efficiency and process optimization. Bensen plays a crucial role in implementing the operational strategy.
